AMBULATORY REFLUX MONITORING GUIDES PROTON PUMP INHIBITOR DISCONTINUATION IN PATIENTS WITH GASTROESOPHAGEAL REFLUX SYMPTOMS: A CLINICAL TRIAL

BACKGROUND & AIMS: Proton pump inhibitor (PPI) therapy fails to provide adequate symptom control in up to 50% of patients with gastroesophageal reflux symptoms. While a proportion do not require ongoing PPI therapy, a diagnostic approach to identify candidates appropriate for PPI cessation is no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterology
Main Authors: Yadlapati, Rena, Masihi, Melina, Gyawali, C. Prakash, Carlson, Dustin A, Kahrilas, Peter J., Nix, Billy Darren, Jain, Anand, Triggs, Joseph R., Vaezi, Michael F., Kia, Leila, Kaizer, Alexander, Pandolfino, John E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755671/
https://ncbi.nlm.nih.gov/pubmed/32949568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2020.09.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados